TrialHealth and quality of life outcomes2012

Estimating quality adjusted progression free survival of first-line treatments for EGFR mutation positive non small cell lung cancer patients in The Netherlands.

S Cora Verduyn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.